Upgrade to SI Premium - Free Trial

Amicus Therapeutics (FOLD) Misses Q2 EPS by 3c

August 8, 2019 7:20 AM
Amicus Therapeutics (NASDAQ: FOLD) reported Q2 EPS of ($0.36), $0.03 worse than the analyst estimate of ($0.33). Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Earnings Guidance

Next Articles